Drug affinity complex raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-06-26. Anything still debated is marked as such rather than presented as settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | Built on a 29 residue sequence |
| Primary target | GHRH receptor (GHRHR) | Class B G protein coupled receptor |
| Unconjugated half life | Minutes | Limited by protease degradation |
| Key modification | Four residue substitutions | Positions 2, 8, 15 and 27 |
| Common synonym | Modified GRF(1-29) | Usually denotes the form without DAC |
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
=== Musculoskeletal symptoms === Joint instability and soft tissue injuries: Dislocations, subluxations, or damage to muscles, ligaments, tendons, synovium, or cartilage as a result of excessive joint movement. Chronic pain: Recurrent joint pain that can develop into hyperalgesia, with a higher rate of small fiber neuropathy in some individuals. Disturbed proprioception: Reduced proprioception and muscle weakness, creating a cycle of increasing activity limitations
== Selected bibliography == Daly, Marie M.; Mirsky, A.E. (June 1949). "Chromatography of Purines and Pyrimidines on Starch Columns". Journal of Biological Chemistry. 179 (2): 981–982. doi:10.1016/S0021-9258(19)51291-1. PMID 18150028. Daly, M.M.; Allfrey, V.G.; Mirsky, A.E. (May 20, 1950). "Purine and Pyrimidine Contents of Some Desoxypentose Nucleic Acids" (PDF). Journal of General Physiology. 33 (5): 497–510. doi:10.1085/jgp.33.5.497. PMC 2147206. PMID 15422104. Daly, Marie; Mirsky, A.E.; Ris, Hans (March 20, 1951). "The Amino Acid Composition and Some Properties of Histones" (PDF). The Journal of General Physiology. 34 (4): 439–450. doi:10.1085/jgp.34.4.439. PMC 2147226. PMID 14824510. Daly, Marie M.; Mirsky, A.E. (November 1952). "Formation of Protein in the Pancreas". Journal of General Physiology. 36 (2): 243–254. doi:10.1085/jgp.36.2.243. PMC 2147369. PMID 13011280. Daly, Marie M.; Allfrey, V.G.; Mirsky, A.E. (November 1952). "Uptake of Glycine-N15 by Components of Cell Nuclei" (PDF). Journal of General Physiology. 36 (2): 173–179. doi:10.1085/jgp.36.2.173. PMC 2147362. PMID 13011275. Allfrey, V.; Daly, M.M.; Mirsky, A.E. (November 20, 1953). "Synthesis of protein in the pancreas. II. The role of ribonucleoprotein in protein synthesis". Journal of General Physiology. 37 (2): 157–175. doi:10.1085/jgp.37.2.157. PMC 214743. PMID 13109153. Mirsky, A.E.; Allfrey, V.G.; Daly, M.M. (September 1954). "The Uptake of N15-Labelled Glycine by Liver Proteins". Journal of Histochemistry and Cytochemistry. 2 (5): 376–377. doi:10.1177/2.5.376. PMID 13192326. S2CID 40223958.
The three substrates of this enzyme are asparagusic acid, reduced nicotinamide adenine dinucleotide (NADH), and a proton. Its products are 3-mercapto-2-mercaptomethylpropanoic acid and oxidised NAD+. This enzyme belongs to the family of oxidoreductases, specifically those acting on a sulfur group of donors with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is 3-mercapto-2-mercaptomethylpropanoate:NAD+ oxidoreductase. Other names in common use include asparagusate dehydrogenase, asparagusic dehydrogenase, asparagusate reductase (NADH2), and NADH2:asparagusate oxidoreductase.
==== Indigenous affairs ==== Upon taking office, Lula also issued the Provisional measure No. 1,154, of 1 January 2023, which created the Ministry of Indigenous People, and also renamed the Fundação Nacional do Índio ("National Indian Foundation, FUNAI") to Fundação Nacional dos Povos Indígenas ("National Indigenous People Foundation"), in addition to linking this foundation authority to the newly created ministry (it was previously linked to the Ministry of Agriculture). He appointed Sônia Guajajara as Indigenous minister, and Joenia Wapichana to head FUNAI, being the first indigenous women to head such offices. On 3 January 2023, Joenia Wapichana announced the creation of several working groups to resume the demarcation of indigenous lands that had been paralyzed in the previous years (such as the Jeju and Areal Indigenous Lands in Pará, Tekoha Porã, Karugwá and Pyhaú lands in São Paulo, Ka'aguy Poty in Rio Grande do Sul, Cambirela in Santa Catarina, Passo Piraju/Nu Porã in Mato Grosso do Sul and the area claimed by the Mukurin people in Minas Gerais), in addition to establishing new groups (for the Aranã and Aranã Caboclo Índio indigenous lands in Minas Gerais and the areas claimed by the Cassupá and Salamãi ethnic groups in Rondônia).
Sources: en.wikipedia.org
In the first half of the 16th century Paracelsus proposed a theory of mineral formation as an analogy to fruit-bearing plants. In 1550 Gerolamo Cardano made an early attempt to explain the shape of crystals as the result of a close packing of spheres. In 1591 Thomas Harriot studied the close packing of cannonballs (spheres). In 1597 Andreas Libavius recognized the geometrical characteristics of crystals and identified salts from their crystal shape.
=== 31 January === US President Joe Biden said no to sending F-16s fighter jets to Ukraine after being asked by a reporter. A spokesman for British PM Rishi Sunak said it was not practical for the UK to supply Ukraine with fighter jets. Two US government officials said that the US was preparing a $2 billion aid package to Ukraine which included Ground Launched Small Diameter Bombs with a range of around 150 km (93 mi).
=== Allergy === Molecular diagnostics is increasingly used in allergology, especially for food and respiratory allergy. Conventional diagnosis is based on clinical history, skin-prick testing and measurement of serum allergen-specific IgE to whole allergen extracts. Molecular-based allergy diagnostics, also called component-resolved diagnostics, measures IgE to individual allergen molecules rather than only to extracts. This can help distinguish genuine sensitization from cross-reactivity, refine assessment of clinical risk in some allergies, and support decisions about allergen immunotherapy. Multiplex platforms, such as Allergy Explorer (ALEX), can test IgE reactivity to many allergen extracts and molecular components in a single assay. Precision allergy molecular diagnosis (PAMD®) is a broader diagnostic approach using molecular IgE profiles to guide prognosis, risk assessment and personalized management, although results must be interpreted together with the patient’s clinical history.
Di-tert-butyl dicarbonate is a reagent widely used in organic synthesis. Since this compound can be regarded formally as the acid anhydride derived from a tert-butoxycarbonyl (Boc) group, it is commonly referred to as Boc anhydride. This pyrocarbonate reacts with amines to give N-tert-butoxycarbonyl or so-called Boc derivatives. These carbamate derivatives do not behave as amines, which allows certain subsequent transformations to occur that would be incompatible with the amine functional group. The Boc group can later be removed from the amine using moderately strong acids (e.g., trifluoroacetic acid). Thus, Boc serves as a protective group, for instance in solid phase peptide synthesis. Boc-protected amines are unreactive to most bases and nucleophiles, allowing for the use of the fluorenylmethyloxycarbonyl group (Fmoc) as an orthogonal protecting group.
=== Cartilage implants === In July 2016, the U.S. approved the use of a synthetic cartilage implant to treat arthritis in the joint of the big toe. The implant is made of saline and a bio-compatible polymer, and is inserted through an incision between the metatarsophalangeal (MTP) joint where natural cartilage has worn away. It is being researched for use in other joints. A separate orthopedic implant consisting of a hydrated, interpenetrating dual polymer network based on polyether urethane (PEU) was given breakthrough device designation from the U.S. Food and Drug Administration in July 2021. In September 2021, researchers used nasal chondrocyte-based engineered cartilage to treat osteoarthritic joints in two patients.
Sources: en.wikipedia.org
== Adverse effects == In September 2020, the US Food and Drug Administration (FDA) required the boxed warning be updated for all benzodiazepine medicines to describe the risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions consistently across all the medicines in the class.
This region is as extensive as the Amazon basin but has a very different climate as it lies farther south at a higher altitude. In the interior northeast, seasonal rainfall is even more extreme. South of Bahia, near the coasts, and more southerly most of the state of São Paulo, the distribution of rainfall changes, with rain falling throughout the year. The south enjoys subtropical conditions, with cool winters and average annual temperatures not exceeding 18 °C (64.4 °F); winter frosts and snowfall are not rare in the highest areas. The semiarid climatic region generally receives less than 800 millimeters (31.5 in) of rain, most of which generally falls in a period of three to five months of the year and occasionally less than this, creating long periods of drought. Brazil's 1877–78 Grande Seca (Great Drought), the worst in Brazil's history, caused approximately half a million deaths. A similarly devastating drought occurred in 1915. In 2024, for the first time, "a drought has covered all the way from the North to the country's Southeast". It is the strongest drought in Brazil since the beginning of measurement in the 1950s, covering almost 60% of the country's territory. The drought is linked to deforestation and climate change.
Obesity in children is treated with dietary changes and physical activity, often through an intensive counselling and lifestyle changes program. At least sixty minutes of daily moderate to high intensity aerobic physical activity is recommended for all children (regardless of BMI). Dieting, including caloric restriction or very low calorie diets, and missing meals should however be discouraged, as it is associated with psychological harm, risks of dietary or nutritional deficiencies and a risk of developing eating disorders later in life. The benefit of tracking BMI and providing counselling around weight is minimal. Brief primary care weight management interventions (e.g. delivered by a physician or nurse practitioner) have only a marginal positive effect in reducing childhood overweight or obesity.
Poly(p-phenylene sulfide) (PPS) is synthesized by the reaction of sodium sulfide with p-dichlorobenzene in a polar solvent such as 1-methyl-2-pyrrolidinone (NMP). It is inherently flame-resistant and stable toward organic and aqueous conditions; however, it is somewhat susceptible to oxidants. Applications of PPS include automotive, microwave oven components, coatings for cookware when blended with fluorocarbon polymers, and protective coatings for valves, pipes, electromotive cells, etc.
Sources: en.wikipedia.org
The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.
DAC stands for drug affinity complex, a term describing the maleimidopropionic acid linker. This group forms a covalent bond with the cysteine residue on serum albumin after administration. The resulting adduct is what extends the circulating half life from minutes to days.
No. It is entirely synthetic and does not correspond to any known endogenous peptide. The design starts from human growth hormone releasing hormone and introduces deliberate substitutions. Any biological effect comes from mimicking the natural hormone at its receptor.
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.